DK1189929T3 - Faktor VIIa-inhibitorer - Google Patents

Faktor VIIa-inhibitorer

Info

Publication number
DK1189929T3
DK1189929T3 DK00938691T DK00938691T DK1189929T3 DK 1189929 T3 DK1189929 T3 DK 1189929T3 DK 00938691 T DK00938691 T DK 00938691T DK 00938691 T DK00938691 T DK 00938691T DK 1189929 T3 DK1189929 T3 DK 1189929T3
Authority
DK
Denmark
Prior art keywords
factor viia
viia inhibitors
inhibitors
factor
viia
Prior art date
Application number
DK00938691T
Other languages
English (en)
Inventor
Otmar Klingler
Manfred Schudok
Gerhard Zoller
Uwe Heinelt
Elisabeth Defossa
Hans Matter
Pavel Safar
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1189929T3 publication Critical patent/DK1189929T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK00938691T 1999-06-08 2000-05-27 Faktor VIIa-inhibitorer DK1189929T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99111109A EP1059302A1 (en) 1999-06-08 1999-06-08 Factor VIIa inhibitors
PCT/EP2000/004846 WO2000075172A2 (en) 1999-06-08 2000-05-27 FACTOR VIIa INHIBITORS

Publications (1)

Publication Number Publication Date
DK1189929T3 true DK1189929T3 (da) 2003-11-24

Family

ID=8238315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00938691T DK1189929T3 (da) 1999-06-08 2000-05-27 Faktor VIIa-inhibitorer

Country Status (32)

Country Link
US (1) US6500803B1 (da)
EP (2) EP1059302A1 (da)
JP (1) JP4546683B2 (da)
KR (1) KR100979069B1 (da)
CN (1) CN1359390B (da)
AR (1) AR024292A1 (da)
AT (1) ATE246707T1 (da)
AU (1) AU774037B2 (da)
BR (1) BR0011461A (da)
CA (1) CA2376064C (da)
CZ (1) CZ300365B6 (da)
DE (1) DE60004363T2 (da)
DK (1) DK1189929T3 (da)
EE (1) EE04855B1 (da)
ES (1) ES2202137T3 (da)
HK (1) HK1047289B (da)
HR (1) HRP20010912B1 (da)
HU (1) HUP0201451A3 (da)
IL (2) IL146731A0 (da)
ME (1) MEP57708A (da)
MX (1) MXPA01012568A (da)
NO (1) NO328249B1 (da)
NZ (1) NZ515966A (da)
PL (1) PL202879B1 (da)
PT (1) PT1189929E (da)
RS (1) RS50415B (da)
RU (1) RU2248359C2 (da)
SI (1) SI1189929T1 (da)
SK (1) SK286902B6 (da)
TR (1) TR200103550T2 (da)
WO (1) WO2000075172A2 (da)
ZA (1) ZA200110053B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1059302A1 (en) * 1999-06-08 2000-12-13 Aventis Pharma Deutschland GmbH Factor VIIa inhibitors
DE10005631A1 (de) * 2000-02-09 2001-08-23 Max Planck Gesellschaft Arginin-Mimetika als Faktor X¶a¶-Inhibitoren
GB0014134D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
JP4179878B2 (ja) * 2001-02-02 2008-11-12 中外製薬株式会社 ペプチド誘導体
GB0127615D0 (en) * 2001-07-09 2002-01-09 Aventis Pharm Prod Inc Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
BRPI0413555A (pt) 2003-08-18 2006-10-17 Lundbeck & Co As H composto ou sal do mesmo, composição farmacêutica, uso de um composto ou sal, e, método para o tratamento de uma doença, para a fabricação de um composto e para a preparação de composto
TWI453198B (zh) 2005-02-16 2014-09-21 Lundbeck & Co As H 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s）-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
TWI376373B (en) 2005-02-16 2012-11-11 Lundbeck & Co As H Crystalline base of a pharmaceutical compound
DE602006011752D1 (de) * 2005-06-24 2010-03-04 Bristol Myers Squibb Co Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
US20080070987A1 (en) * 2006-05-12 2008-03-20 Francesc Yraola Font Meta-xylylenediamine vanadate salts
AU2017273857B2 (en) 2016-06-01 2021-08-19 Athira Pharma, Inc. Compounds
CA3145453A1 (en) 2019-07-01 2021-01-07 Tonix Pharma Limited Anti-cd154 antibodies and uses thereof
MX2023008055A (es) 2021-01-06 2023-08-22 Tonix Pharma Ltd Métodos para inducir tolerancia inmune con anticuerpos anti-cd154 modificados.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023236A (en) * 1988-04-07 1991-06-11 Corvas, Inc. Factor VII/VIIA active site inhibitors
US5506134A (en) 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5833982A (en) 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
US5788965A (en) 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SI9520044B (sl) * 1994-04-26 2004-08-31 Aventis Pharmaceuticals Inc. Inhibitorji Xa faktorja
AU2056197A (en) * 1996-02-22 1997-09-10 Du Pont Merck Pharmaceutical Company, The M-amidino phenyl analogs as factor xa inhibitors
AR013084A1 (es) * 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
EP0987274A1 (en) * 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors
EP1059302A1 (en) * 1999-06-08 2000-12-13 Aventis Pharma Deutschland GmbH Factor VIIa inhibitors

Also Published As

Publication number Publication date
AU774037B2 (en) 2004-06-17
SK17592001A3 (sk) 2002-05-09
PL202879B1 (pl) 2009-07-31
HRP20010912B1 (en) 2010-10-31
DE60004363D1 (de) 2003-09-11
IL146731A (en) 2007-07-24
PL352200A1 (en) 2003-08-11
CN1359390B (zh) 2010-05-26
EP1059302A1 (en) 2000-12-13
EE04855B1 (et) 2007-06-15
TR200103550T2 (tr) 2002-05-21
HK1047289A1 (en) 2003-02-14
JP4546683B2 (ja) 2010-09-15
EP1189929A2 (en) 2002-03-27
HRP20010912A2 (en) 2003-04-30
DE60004363T2 (de) 2004-06-24
ATE246707T1 (de) 2003-08-15
HUP0201451A2 (en) 2002-08-28
US6500803B1 (en) 2002-12-31
CA2376064C (en) 2011-04-26
NO20016005L (no) 2002-02-06
KR20020020728A (ko) 2002-03-15
JP2003502294A (ja) 2003-01-21
HK1047289B (zh) 2010-10-22
PT1189929E (pt) 2003-12-31
EP1189929B1 (en) 2003-08-06
NO20016005D0 (no) 2001-12-07
CN1359390A (zh) 2002-07-17
RU2248359C2 (ru) 2005-03-20
CZ300365B6 (cs) 2009-04-29
HUP0201451A3 (en) 2003-08-28
EE200100662A (et) 2003-04-15
CA2376064A1 (en) 2000-12-14
AU5397600A (en) 2000-12-28
RS50415B (sr) 2009-12-31
MXPA01012568A (es) 2002-04-10
BR0011461A (pt) 2002-03-19
ES2202137T3 (es) 2004-04-01
ZA200110053B (en) 2002-07-03
YU86101A (sh) 2004-07-15
SK286902B6 (sk) 2009-07-06
WO2000075172A3 (en) 2001-05-31
CZ20014357A3 (cs) 2002-03-13
KR100979069B1 (ko) 2010-08-31
MEP57708A (en) 2011-05-10
WO2000075172A2 (en) 2000-12-14
AR024292A1 (es) 2002-09-25
IL146731A0 (en) 2002-07-25
NO328249B1 (no) 2010-01-18
SI1189929T1 (en) 2004-02-29
NZ515966A (en) 2003-09-26

Similar Documents

Publication Publication Date Title
NO20011293D0 (no) Faktor VIIa-inhibitorer
NO20021230L (no) Faktor Xa inhibitorer
PT1181017E (pt) Inibidores de metaloproteases
DE60014610D1 (de) Glukokinase aktivatoren
NO20022863D0 (no) Trans-olefiniske glycokinase aktivatorer
NO20001687D0 (no) Benzamidinderivater som faktor Xa-inhibitorer
NO20013072L (no) Nitrogenholdige heterocykler som faktor Xa-inhibitorer
NO20003808L (no) Substituerte oksoazaheterosyklylfaktor Xa inhibitorer
DE60020259D1 (de) C-aryl-glucosid-sglt2-inhibitoren
DE60017180D1 (de) Fab i inhibitoren
DE60044873D1 (de) Orientierte biopolymermembrane
PT1194404E (pt) Inibidores de aspartil-protease
DK1189929T3 (da) Faktor VIIa-inhibitorer
DE60003212D1 (de) Druckkopf
DE10080545D2 (de) Werktisch
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
DE60206376D1 (de) Faktor xa inhibitor
DE60037785D1 (de) Wellenformentzerrer
DE60008319D1 (de) IL-12 Produktionsinhibitor
SE9900233D0 (sv) Navigationsinstrument
FI990517A0 (fi) Suutin
SE9902851D0 (sv) Dammsugarmunstycke
SE9901990D0 (sv) Dammsugarmunstycke
DK199901689A (da) Coating
SE9903473D0 (sv) Quercetin m m